WARNINGS AND PRECAUTIONS ----------------
Boxed Warning 12/2021 Indication and Usage (1) 12/2021 Dosage and Administration (2.1) 12/2021 Warnings and Precautions (5.2, 5.6, 5.8, 5.11) 12/2021 ... Pregnancy: May cause extrapyramidal and/or withdrawal symptoms in neonates with ... especially during the initial few months of drug therapy, and at times of dosage changes. Counsel family ...
Download WARNINGS AND PRECAUTIONS ----------------
Information
Domain:
Source:
Link to this page:
Related documents
Cytotec® - Food and Drug Administration
www.accessdata.fda.govpregnant women to induce labor or to induce abortion beyond the eighth week of pregnancy (see also precautions, and labor and delivery). cytotec should not be taken by pregnant women to reduce the risk of ulcers induced by non-steroidal anti-inflammatory drugs …
The ultimate pregnancy to-do list
assets.babycenter.comSmoking raises the risk of a host of pregnancy problems, including miscarriage and preterm birth. Make sure your activities are pregnancy-safe High caffeine consumption is …
See full prescribing information for complete boxed ...
labeling.bayerhealthcare.com3 FULL PRESCRIBING INFORMATION WARNING: HEPATOTOXICITY • Severe and sometimes fatal hepatotoxicity has occurred in clinical trials [see Warnings and Precautions (5.1)]. • Monitor hepatic function prior to and during treatment [see Warnings and Precautions (5.1)]. • Interrupt and then reduce or discontinue STIVARGA for hepatotoxicity as manifested by elevated liver
HIGHLIGHTS OF PRESCRIBING INFORMATION TIVDAK ...
seagendocs.comWARNING: OCULAR TOXICITY . See full prescribing information for complete boxed warning. • • TIVDAK caused changes in the corneal epithelium and conjunctiva resulting in changes in vision, including severe vision loss, and corneal ulceration . (5.1) •
HEADACHES - University of California, Berkeley
uhs.berkeley.eduappearance of warning signs 30-60 minutes before the onset of headache symptoms. Aura symptoms are usually neurologic in nature and may include visual disturbances (e.g. seeing wavy lines, dots, flashing lights, blind spots) and disruptions in smell, taste, or touch. ... Avoid during pregnancy and when taking NSAIDS such
HIGHLIGHTS OF PRESCRIBING INFORMATION Administer at …
www.gene.comSee full prescribing information for complete boxed warning Cardiomyopathy: Herceptin can resultin subclinical and clinical cardiac failure manifesting as CHF, and decreased LVEF, with greatest risk when administered concurrently with anthracyclines. Evaluate cardiac function prior to and during treatment. Discontinue Herceptin for
HIGHLIGHTS OF PRESCRIBING INFORMATION CAR-positive …
www.novartis.usWARNING: CYTOKINE RELEASE SYNDROME positive and ... 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use ... Ensure tocilizumab and emergency equipment are available prior …
Prescribing Information | SUBLOCADE® (buprenorphine ...
www.sublocade.comuse of opioids during pregnancy. (5.7) Adrenal Insufficiency: If diagnosed, treat with physiologic replacement of corticosteroids, and wean patient off of the opioid. (5.8) Risk of Opioid Withdrawal With Abrupt Discontinuation: If treatment with SUBLOCADE is discontinued, monitor patients for several months for withdrawal and treat appropriately.